Viewing Study NCT02300558


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-03-11 @ 2:10 AM
Study NCT ID: NCT02300558
Status: TERMINATED
Last Update Posted: 2018-01-12
First Post: 2014-11-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Long QT Syndrome Type 3 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 3 long QT syndrome (LQT3) View
None Long QT syndrome View
None Congenital long QT View
None Sudden cardiac death View